Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Construction and validation of a immune-related prognostic gene DHRS1 in hepatocellular carcinoma based on bioinformatic analysis. | Medicine (Baltimore) | 2023 | 37861541 | PubTator, text mining | PubMed |
| In vitro vascularized immunocompetent patient-derived model to test cancer therapies. | iScience | 2023 | 37860774 | PubTator, text mining | PubMed |
| Unraveling molecular networks in thymic epithelial tumors: deciphering the unique signatures. | Front Immunol | 2023 | 37849766 | PubTator, text mining | PubMed |
| Single cell and bulk transcriptome analysis identified oxidative stress response-related features of Hepatocellular Carcinoma. | Front Cell Dev Biol | 2023 | 37842089 | PubTator, text mining | PubMed |
| Immunotherapy and biomarkers in patients with lung cancer with tuberculosis: Recent advances and future Directions. | iScience | 2023 | 37841590 | PubTator, text mining | PubMed |
| Identification of specific prognostic markers for lung squamous cell carcinoma based on tumor progression, immune infiltration, and stem index. | Front Immunol | 2023 | 37841237 | PubTator, text mining | PubMed |
| Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancer. | NPJ Precis Oncol | 2023 | 37838778 | PubTator, text mining | PubMed |
| Role of DNA Methylation Profiles as Potential Biomarkers and Novel Therapeutic Targets in Head and Neck Cancer. | Cancers (Basel) | 2023 | 37835379 | PubTator, text mining | PubMed |
| Prognostic Factors in Advanced Non-Small Cell Lung Cancer Patients Treated with Immunotherapy. | Cancers (Basel) | 2023 | 37835378 | PubTator, text mining | PubMed |
| LncRNA RARA-AS1 could serve as a novel prognostic biomarker in pan-cancer and promote proliferation and migration in glioblastoma. | Sci Rep | 2023 | 37833349 | PubTator, text mining | PubMed |
| Comprehensive bioinformatics analysis of the role of VWF in the tumor microenvironment of malignant mesothelioma. | Medicine (Baltimore) | 2023 | 37832118 | PubTator, text mining | PubMed |
| The role of CD4+ T cells in tumor and chronic viral immune responses. | MedComm (2020) | 2023 | 37829505 | PubTator, text mining | PubMed |
| Hypomethylation-induced regulatory programs in T cells unveiled by transcriptomic analyses. | Front Immunol | 2023 | 37828996 | PubTator, text mining | PubMed |
| Regulating the regulatory T cells as cell therapies in autoimmunity and cancer. | Front Med (Lausanne) | 2023 | 37828948 | PubTator, text mining | PubMed |
| Ewing Sarcoma Single-cell Transcriptome Analysis Reveals Functionally Impaired Antigen-presenting Cells. | Cancer Res Commun | 2023 | 37823774 | PubTator, text mining | PubMed |
| Immune Cell Abundance and T-cell Receptor Landscapes Suggest New Patient Stratification Strategies in Head and Neck Squamous Cell Carcinoma. | Cancer Res Commun | 2023 | 37819239 | PubTator, text mining | PubMed |
| Incompetent memory immune response in severe COVID-19 patients under treatment. | Heliyon | 2023 | 37817995 | PubTator, text mining | PubMed |
| Microenvironmental network of clonal CXCL13+CD4+ T cells and Tregs in pemphigus chronic blisters. | J Clin Invest | 2023 | 37815865 | PubTator, text mining | PubMed |
| Patient-derived precision cut tissue slices from primary liver cancer as a potential platform for preclinical drug testing. | EBioMedicine | 2023 | 37806285 | PubTator, text mining | PubMed |
| Gastric cancer metastasis-related NT5DC2 indicates unfavorable prognosis of patients. | Medicine (Baltimore) | 2023 | 37800836 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=17